The Catechol-O-Methyltransferase val158met polymorphism contributes to the risk of breast cancer in the Chinese population: An updated meta-analysis

Journal of Breast Cancer

Volumn 17, Issue 2, 2014, Pages 149-156

  Wan, Guo Xing ^a   Cao, Yu Wen ^a   Li, Wen Qin ^a   Li, Yu Cong ^a   Li, Feng ^a  

^a SHIHEZI UNIVERSITY   (China)

Author keywords

Breast neoplasms; Catechol O methyltransferase; Genetic; Meta analysis; Polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; META ANALYSIS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREMENOPAUSE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TUMOR GENE;

EID: 84903993455     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2014.17.2.149     Document Type: Article

References (28)

1. Wang YC, Wei LJ, Liu JT, Li SX, Wang QS. Comparison of cancer incidence between China and the USA. Cancer Biol Med 2012;9:128-132.
2. Qin X, Peng Q, Qin A, Chen Z, Lin L, Deng Y, et al. Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis. Diagn Pathol 2012;7:136.
3. Lin WY, Chou YC, Wu MH, Jeng YL, Huang HB, You SL, et al. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan. Cancer Detect Prev 2005;29:427-432.
4. Lajin B, Hamzeh AR, Ghabreau L, Mohamed A, Al Moustafa AE, Alachkar A. Catechol-O-methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria. Breast Cancer 2013;20:62-66.
5. Wen W, Ren Z, Shu XO, Cai Q, Ye C, Gao Y T, et al. Expression of cyto-chrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk. Cancer Epidemiol Bio-markers Prev 2007;16:917-920.
6. Yager JD. Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer. Drug Discov Today Dis Mech 2012; 9:e41-e46.
7. Xu YJ, Ge YL, Zhang JY, Li FN, Zheng Z. Polymorphism of COMT, p21 and NuMA in sporadic breast cancer. Chin J Clin 2010;4:591-596.
8. Tan W, Qi J, Xing DY, Miao XP, Pan KF, Zhang L, et al. Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women. Zhong-hua Zhong Liu Za Zhi 2003;25:453-456.
9. Chang TW, Wang SM, Guo YL, Tsai PC, Huang CJ, Huang W. Glutathi-one S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan. Breast 2006;15:754-761.
10. Cheng TC, Chen ST, Huang CS, Fu Y P, Yu JC, Cheng C W, et al. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 2005;113:345-353.
11. Fan Y, Feng Y, Wang L, Wang Y, Fu L. Te relationship between cate-chol-O-methyltransferase (COMT) polymorphisms and the development of breast cancer. Chin J Clin Oncol 2007;34:430-433.
12. Hu Z, Song CG, Lu JS, Luo JM, Shen ZZ, Huang W, et al. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or afected relatives. J Cancer Res Clin Oncol 2007;133:969-978.
13. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 1999;59:4870-4875.
14. Lin SC, Chou YC, Wu MH, Wu CC, Lin WY, Yu CP, et al. Genetic variants of myeloperoxidase and catechol-O-methyltransferase and breast cancer risk. Eur J Cancer Prev 2005;14:257-261.
15. Shrubsole MJ, Lu W, Chen Z, Shu XO, Zheng Y, Dai Q, et al. Drinking green tea modestly reduces breast cancer risk. J Nutr 2009;139:310-316.
16. Wang Q, Li H, Tao P, Wang YP, Yuan P, Yang CX, et al. Soy isofavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China. DNA Cell Biol 2011;30:585-595.
17. Wang Q, Wang YP, Li JY, Yuan P, Yang F, Li H. Polymorphic catechol-O-methyltransferase gene, soy isofavone intake and breast cancer in post-menopausal women: a case-control study. Chin J Cancer 2010;29:683-688.
18. Wen W, Cai Q, Shu XO, Cheng JR, Parl F, Pierce L, et al. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis. Cancer Epidemiol Biomarkers Prev 2005;14:329-335.
19. Wu AH, Tseng CC, Van Den Berg D, Yu MC. Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res 2003; 63:7526-7529.
20. He XF, Wei W, Li SX, Su J, Zhang Y, Ye XH, et al. Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls. Mol Biol Rep 2012;39: 6811-6823.
21. Ding H, Fu Y, Chen W, Wang Z. COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies. Breast Cancer Res Treat 2010;123:265-270.
22. Mao C, Wang X W, Qiu LX, Liao RY, Ding H, Chen Q. Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat 2010;121:719-725.
23. Higgins JP, Tompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
24. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
25. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
26. Goodman JE, Jensen LT, He P, Yager JD. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. Pharmacogenetics 2002;12:517-528.
27. Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 2001;61:6716-6722.
28. Srivastava K, Srivastava A. Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk. PLoS One 2012;7:e50966.